Increasing RSV vaccination of older adults has the potential to reduce associated hospitalizations and severe clinical outcomes. Corresponding Author: To contact the corresponding author, Fiona P.

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — they’re not just another dose of last year’s protection. The coronavirus and influenza are escape artists that ...

phenomena and Respiratory Syncytial Virus (RSV), and these low temps can make it harder for your immune system to fight off ...

RSV is a common cause of coughs and colds but can also lead to severe respiratory illness, especially in the most vulnerable.

Respiratory syncytial virus, or RSV, is a virus that causes infections of the lungs and breathing passages. It is highly ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.

Ardent Solutions, in partnership with the Allegany County Department of Health, is hosting a series of vaccination clinics in November as part of the U.S. Department of Health ...